干血斑块中的类固醇激素度:毛细血管和静脉血液样本之间的比较
Anouk Olthof1, Vera H de Kleijne1, Anita Boelen2
1Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location University of Amsterdam, Amsterdam Gastroenterology Endocrinology & Metabolism, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Gastroenterology Endocrinology & Metabolism, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands.
Clinica chimica acta; international journal of clinical chemistry
|December 19, 2024
概括
在EDTA管中的静脉血液中的干血斑 (DBS) 适合开发类固醇激素的液体染色学-并联质谱法 (LC-MS/MS) 方法. 这种方法为采样提供了一个可行的替代方案,不包括皮质激素分析.
科学领域:
- 生物化学 生物化学
- 分析化学 分析化学
- 临床实验室科学 临床实验室科学
背景情况:
- 干血斑点 (DBS) 越来越多地用于实验室测量.
- 开发强大的液体染色学-并联质谱法 (LC-MS/MS) 方法需要大量的DBS样本.
- 静脉血液在临床环境中很容易获得,可用于准备DBS.
研究的目的:
- 评估从静脉血液 (采集在EDTA管中) 中制备的DBS适合开发和验证LC-MS/MS方法.
- 为了确定静脉血液衍生的DBS是否可以与毛细血管DBS相比,可靠地量化类固醇激素.
主要方法:
- 从20名健康志愿者收集了毛细血管和静脉血液样本 (EDTA和非EDTA管).
- 从静脉血液样本中制备的体积DBS.
- 使用内部LC-MS/MS方法分析了类固醇激素 (,安德罗斯,17-OHP,皮质醇,皮质素,皮质,DHEA-S).
主要成果:
- 来自静脉EDTA管的DBS显示了大多数类固醇激素与毛细血管DBS的高相关性 (≥0.89),除了皮质 (0.67).
- 来自非EDTA静脉管的DBS与EDTA静脉DBS (≥0.97) 和毛细血管DBS (>0.90) 强烈相关,不包括皮质 (0.64).
结论:
- 从EDTA管中收集的静脉血液中制备的DBS适合开发和验证大多数类固醇激素的LC-MS/MS方法.
- 这种方法为使用LC-MS/MS的类固醇激素分析提供了切实可行的替代方案,除了皮质激素定量.
相关概念视频
Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...


